MarketWatch: Pfizer will go back to price hikes ‘as normal’ come January, CEO suggests

MarketWatch: Pfizer will go back to price hikes ‘as normal’ come January, CEO suggests

Pfizer Inc. will likely go back to “business as normal” for drug price increases